NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) will host a teleconference at 7 p.m. EDT (6 p.m. CDT) on Sunday, June 2, 2013, to review data presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Company executives will provide an overview of data presented at the meeting, with a focus on the immuno-oncology portfolio, and address inquiries from investors and analysts.
Investors and the general public are invited to listen to a live webcast of the call at: http://investor.bms.com or by dialing 913-312-0641, confirmation code: 3075561. Materials related to the call will be available at the same website prior to the call. A replay of the call will be available beginning at 10 p.m. EDT on June 2 through 10 p.m. EDT on June 16. The replay can be accessed at http://investor.bms.com or by dialing 402-280-9013, confirmation code: 3075561.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.